Literature DB >> 10661681

Effects of nicotinamide-related agents on the growth of primary rat hepatocytes and formation of small hepatocyte colonies.

F Sato1, T Mitaka, T Mizuguchi, Y Mochizuki, K Hirata.   

Abstract

AIMS/
BACKGROUND: We report in this study that, 10 mM nicotinamide can stimulate the proliferation of primary rat hepatocytes in serum-free Dulbecco's modified Eagle's medium supplemented with 10 ng/ml epidermal growth factor and that small hepatocyte colonies appear from 4 to 5 days after plating. We examined the effects of nicotinamide-related agents on the growth and differentiation of primary rat hepatocytes and on the appearance of small hepatocyte colonies.
METHODS: As nicotinamide is an aqueous vitamin named niacin and known to act as an inhibitor of poly (ADP-ribose) polymerase (PARP), we therefore chose to examine the effects on hepatocytes of three nicotinamide-related agents, nicotinic acid (NA) which is also a niacin, 3-aminobenzamide (3-AB) which is a strong inhibitor of PARP but is not a niacin, and 3-acetylpyridine (3-AP) which is a weak inhibitor of PARP and also not a niacin. To examine their effects on the growth of the cells and on the formation of the colony, immunocytochemistry for BrdU was carried out. Expression of albumin, tryptophan 2,3-dioxygenase (TO), and connexin 32 (Cx32) mRNAs were used as marks of hepatic differentiation. Intracellular NAD+ content was also measured.
RESULTS: At concentration of 10 mM, NA could not enhance the proliferation of mature hepatocytes but induced the appearance of small hepatocyte colonies. At concentration of 5 mM, 3-AB enhanced the proliferation of the hepatocytes but did not induce small hepatocyte colonies. On the other hand, although 10 mM 3-AP remarkably inhibited the DNA synthesis of the cells, the expression not only of albumin but also of TO and Cx32 mRNAs in the cells was well maintained for more than one week. The intracellular NAD+ concentration was correlated with the proliferation of the hepatocytes.
CONCLUSION: These results suggest that the intracellular NAD+ content may be correlated with the proliferation of primary hepatocytes and that the supplementation of niacin in the medium may be important for the appearance of small hepatocyte colonies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10661681     DOI: 10.1111/j.1478-3231.1999.tb00080.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  10 in total

1.  VEGF(165) expressing bone marrow mesenchymal stem cells differentiate into hepatocytes under HGF and EGF induction in vitro.

Authors:  Yan Tan; En-Hua Xiao; Li-Zhi Xiao; You-Hong Yuan; Cong Ma; Quan-Liang Shang; Du-Jun Bian; Yan-Hui Li; Zhu Chen; Qian Chang
Journal:  Cytotechnology       Date:  2012-04-04       Impact factor: 2.058

2.  Enhanced growth and hepatic differentiation of fetal liver epithelial cells through combinational and temporal adjustment of soluble factors.

Authors:  Lichuan Qian; Diane S Krause; W Mark Saltzman
Journal:  Biotechnol J       Date:  2011-10-26       Impact factor: 4.677

3.  Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry.

Authors:  Xuede Zhang; Wei Li; Yanli Hou; Zequn Niu; Yujie Zhong; Yuping Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

4.  Amniotic mesenchymal stem cells derived hepatocyte-like cells attenuated liver fibrosis more efficiently by mixed-cell transplantation.

Authors:  Hui Wang; Yuan Tian; Xin Li; Meijia Yang; Ying Yan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-02-25

Review 5.  Models and methods for in vitro testing of hepatic gap junctional communication.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2015-09-28       Impact factor: 3.500

6.  Enhanced hepatogenic transdifferentiation of human adipose tissue mesenchymal stem cells by gene engineering with Oct4 and Sox2.

Authors:  Sei-Myoung Han; Ye-Rin Coh; Jin-Ok Ahn; Goo Jang; Soo Young Yum; Sung-Keun Kang; Hee-Woo Lee; Hwa-Young Youn
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 7.  Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases.

Authors:  Yini Wang; Xiaopeng Yu; Ermei Chen; Lanuan Li
Journal:  Stem Cell Res Ther       Date:  2016-05-12       Impact factor: 6.832

Review 8.  Signalling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes.

Authors:  Jun-Song Ye; Xiao-San Su; J-F Stoltz; N de Isla; Lei Zhang
Journal:  Cell Prolif       Date:  2015-02-06       Impact factor: 6.831

9.  Functional Recellularization of Acellular Rat Liver Scaffold by Induced Pluripotent Stem Cells: Molecular Evidence for Wnt/B-Catenin Upregulation.

Authors:  Nesrine Ebrahim; Omnia A M Badr; Mohamed M Yousef; Amira Hassouna; Dina Sabry; Ayman Samir Farid; Ola Mostafa; Hajir A Al Saihati; Yasmin Seleem; Eman Abd El Aziz; Ahmed Hassan Khalil; Ahmed Nawar; Ahmed A Shoulah; Mohammad Aljasir; Amira Zaki Mohamed; Mohamed El-Sherbiny; Nehal M Elsherbiny; Mohamed Ahmed Eladl; Nicholas Robert Forsyth; Rabab F Salim
Journal:  Cells       Date:  2021-10-20       Impact factor: 6.600

10.  Developing a New Two-Step Protocol to Generate Functional Hepatocytes from Wharton's Jelly-Derived Mesenchymal Stem Cells under Hypoxic Condition.

Authors:  Patcharee Prasajak; Wilairat Leeanansaksiri
Journal:  Stem Cells Int       Date:  2013-05-30       Impact factor: 5.443

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.